✦ LIBER ✦

Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors)

✍ Scribed by Jeffrey D. Seidman; Robert J. Kurman

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 32 KB
Volume: 95
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.10777

No coin nor oath required. For personal study only.

✦ Synopsis

Ovarian serous borderline tumors recently were categorized into benign and malignant types. A subset of these tumors, termed “micropapillary serous carcinoma (MPSC),” is reported to behave in a manner similar to low‐grade carcinoma. In this issue of Cancer, Bristow et al. report their experience with 26 patients with recurrent MPSC.

See also pages 677–80 and pages 791–800.

📜 SIMILAR VOLUMES

Recurrent micropapillary serous ovarian

Recurrent micropapillary serous ovarian carcinoma : The role of secondary cytoreductive surgery

✍ Robert E. Bristow; Dana R. Gossett; David R. Shook; Mariana L. Zahurak; Rafael S 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 1 views

## Background: The objectives of the current study were to: 1) characterize the clinical outcome of patients with recurrent micropapillary serous ovarian carcinoma (mpsc) and 2) evaluate the survival impact of secondary cytoreductive surgery and other prognostic variables. ## Methods: Twenty-six

The current status of surgical staging o

The current status of surgical staging of ovarian serous borderline tumors

✍ Paul S. Lin; David M. Gershenson; Michael W. Bevers; Kristin R. Lucas; Thomas W. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Background: The purpose of the current study was to evaluate the current practice of surgical staging of ovarian serous borderline tumors. ## Methods: Women with a diagnosis of ovarian serous borderline tumors whose pathology slides were sent to the m. d. anderson cancer center for second-opin

Serous borderline tumors of the ovary wi

Serous borderline tumors of the ovary with noninvasive peritoneal implants

✍ David M. Gershenson; Elvio G. Silva; Guillermo Tortolero-Luna; Charles Levenback 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

## BACKGROUND. The authors conducted this study to update their experience with patients who have ovarian serous borderline tumors with noninvasive peritoneal implants, with the objectives of gaining additional insight into the biologic behavior of these tumors and understanding better the effects

The effect of cyclooxygenase-2 expressio

The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma

✍ Rouba Ali-Fehmi; Mingxin Che; Ibrahim Khalifeh; John M. Malone; Robert Morris; W 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

## Abstract ## BACKGROUND Cyclooxygenase‐2 (COX‐2) seems to be involved at various steps in the processes of malignant transformation and tumor progression. Investigations have shown that COX‐2 overexpression is associated with increased proliferation, reduced apoptosis, and angiogenesis. ## METH